New obesity drug delivery methods tested in Early-Stage trial
NCT ID NCT07313761
First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This early-stage study tests how the body absorbs an experimental weight-loss drug, maridebart cafraglutide, when given as two different types of injections. About 349 adults with overweight or obesity will receive a single dose to compare drug levels and check for side effects. The goal is to find the best way to deliver the medicine for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anaheim Clinical Trials
Anaheim, California, 92801-2658, United States
-
CenExel Collaborative Neuroscience Research, LLC Los Alamitos
Los Alamitos, California, 90720, United States
-
Clinical Pharmacology Of Miami, LLC
Miami, Florida, 33172-3161, United States
-
Ohio Clinical Trials, Inc.
Columbus, Ohio, 43212, United States
Conditions
Explore the condition pages connected to this study.